Sympathetic ophthalmia is a rare yet serious condition in ophthalmology, where trauma or surgery to one eye triggers inflammation in both eyes. This immune-mediated response can occur shortly after the initial injury or even years later. The immune system mistakenly attacks healthy tissues in the uninjured eye, leading to potential vision loss if not treated promptly. Symptoms include pain, redness, light sensitivity, and blurred vision affecting both eyes. Treatment typically involves corticosteroids or immunosuppressive drugs to halt the immune reaction and prevent further damage. Timely diagnosis and intervention are critical to preserving eyesight. Although uncommon, sympathetic ophthalmia underscores the intricate immune dynamics within ocular health, emphasizing the necessity for vigilant monitoring following eye trauma or surgery.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom